| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Kirwin Patrick D. serves as a Director at PMN. Across recent SEC filings that breaks down to 6 buys and 0 sells. Those positions are worth an estimated $53K at current prices.
Historically, Kirwin Patrick D.'s trades have earned a below-average insider score of 33/100 across 6 rated trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -69.0%.
The biggest single holding is PMN (~$53K) as Director. Net of sales, the recent Form 4 record there shows accumulation of 22,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 22, 2026 | PMN Promis Neurosciences, Inc. | Director | Buy | 4,000 | $11.33 | $45,320.00 | +612.6% | +30.4% | - | |
| Aug 14, 2024 | PMN Promis Neurosciences Inc. | Director | Buy | 10,000 | $1.25 | $12,492.00 | +18.9% | -19.1% | -48.0% | |
| Dec 15, 2022 | PMN Promis Neurosciences Inc. | Director | Buy | 3,000 | $4.63 | $13,890.00 | +12.0% | +8.1% | -74.4% | |
| Dec 9, 2022 | PMN Promis Neurosciences Inc. | Director | Buy | 1,000 | $4.98 | $4,980.00 | +4.2% | -5.0% | -77.0% | |
| Aug 17, 2022 | PMN Promis Neurosciences Inc. | Director | Buy | 4,000 | $5.92 | $23,680.00 | +10.5% | +2.4% | -68.4% |